Company Name | Total Employees |
---|---|
Walgreens Boots Alliance, Inc. | 206000 |
Rite Aid Corporation | 47000 |
High Tide Inc. | 1550 |
111, Inc. | 1520 |
China Jo-Jo Drugstores, Inc. | 939 |
BIMI International Medical Inc. | 296 |
PetMed Express, Inc. | 287 |
MedAvail Holdings, Inc. | 279 |
Harrow Health, Inc. 11.875% Senior Notes due 2027 | 217 |
LifeMD, Inc. | 207 |
Leafly Holdings, Inc. | 121 |
TRxADE HEALTH, Inc. | 8 |
Cracking the code
The pharmaceutical industry has always been a cornerstone of global healthcare, and its workforce is a testament to its vast influence. In 2023, the top 10 pharma companies in the U.S. showcase a diverse range of employee counts, reflecting their operational scales and market reach.
Interestingly, companies like TRxADE HEALTH, Inc. and Leafly Holdings, Inc. have fewer than 300 employees each, indicating their niche market focus or early-stage growth phases. These smaller firms, while not as large in workforce, play crucial roles in innovation and specialized services within the industry.
The employment data of these top pharma companies not only reflects their market positions but also provides insights into their operational strategies. From the retail giants to the specialized firms, each company contributes uniquely to the healthcare landscape, driven by their dedicated workforce.
5 Year Trend in Average Market Capitalization for AbbVie
Annual Comparison of SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline
Average Market Capitalization of Abbvie Annually
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Comparison of Average SG&A Expense Ratio for AstraZeneca, Pfizer, and GlaxoSmithKline Over the Years
Number of Employees for Top 10 Pharma Companies
5 Year Trend in Average Market Capitalization for AbbVie
5 Year Trend in Market Capitalization for AbbVie
Comparison of R&D Expenses for Pfizer and AstraZeneca in 2023
Number of Employees for Top 10 Healthcare Companies
Comparison of Net Income Margin for Glaxosmithkline, AstraZeneca, Takeda, and Eli Lilly Over the Last 8 Quarters